As a wholly owned subsidiary of TGen, an institute with a legacy rooted in genomic research, translational discovery, and high performance computing,
Kaligent is uniquely positioned to commercialize its IP for pharma, payers, and providers. Our work seeks to redefine the patient care
experience and advocate for greater data stewardship, security and management.
Partnered with key technology providers such as Dell, Intel and others, Kaligent seeks to democratize data and insights by providing
flexible consumption models for agile, cost-effective solution deployments driving innovation that benefits all of humanity.
We are currently looking to collaborate and engage with forward looking institutions interested in how we are transforming the industry.